Publication | Closed Access

Synthesis and biological evaluation of the glycoside (25R)-3β,16β-diacetoxy-22-oxocholest-5-en-26-yl β-d-glucopyranoside: A selective anticancer agent in cervicouterine cell lines

Medicinal ChemistryDrug TargetingMedicineGlycobiologySelective Anticancer AgentBiological EvaluationAnti-cancer AgentTumor TargetingCervicouterine Cell LinesPharmacologyRadiation OncologyCarbohydrate-protein InteractionDrug DiscoveryGlycosylation